http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9711843-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
filingDate 1997-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e7eb77d8087b4160044b0acd93a4845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e0eeac38909ea3de9fa7fad58e45d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a857f34b4206e8a1a46f70126466417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d28a5edab2eeeb33438441dbba52d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8001cfc8f84cccb48a274fab69ff9b97
publicationDate 2001-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9711843-A
titleOfInvention Use of mupirocin for the manufacture of a medicine for the treatment of bacterial infections associated with colonization of the nasopharynx by pathogenic organisms
abstract "USE OF MUPIROCIN FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF BACTERIAL INFECTIONS ASSOCIATED WITH NASOPHARINGE COLONIZATION BY PATHOGENIC ORGANISMS Mupirocin or a salt or ester can be used to treat recurrent sinusitis and recurrent cramping, particularly with recurrent ear infections, in particular adapted for administration to the nasopharynx.
priorityDate 1996-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411105990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446596

Total number of triples: 27.